Scientists Turn One Stem Cell Into 14 Million Cancer-Fighting NK Cells
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
20 articles
Chinese researchers developed a breakthrough method to mass-produce powerful immune cells that hunt and destroy cancer tumors.
A first-in-human trial shows CAR-modified stem cell memory T cells outperform standard CAR T cells in expansion, persistence, and complete responses.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
A sweeping review of CAR-T and CAR-NK cell therapies in acute myeloid leukemia, covering clinical trial outcomes, key targets, and next-gen strategies.
Modified immune cells engineered to overcome cancer's defenses completed safety testing in lymphoma patients.
Scientists modified patients' immune cells to better recognize and attack cancer tumors expressing NY-ESO-1 protein.
Engineered immune cells target harmful macrophages in tumors, transforming the cancer environment to boost natural anti-tumor immunity.
Scientists develop CAR T cells that attack tumor-supporting immune cells, showing promise for treating hard-to-target solid cancers.
McGill scientists boosted NK cell cancer-killing power using reversible drug treatment, targeting leukemia, glioblastoma, and triple-negative breast cancer.
Innovative immunotherapy approach converts patient tumor cells into personalized vaccines to fight aggressive brain cancer.
Scientists used precise gene editing to enhance CAR-T cell therapy, creating more effective and persistent cancer treatments.
Revolutionary CRISPR technique bypasses lab manufacturing by programming immune cells to fight cancer directly in the body.
BCG therapy for bladder cancer travels to bone marrow, reprogramming stem cells to produce enhanced immune cells that fight tumors throughout the body.
Scientists identify a mitochondria-proteasome-haem pathway that silences immune cells โ and show bortezomib can fix it in CAR-T therapy.
A phase 1 trial shows Temferon โ a gene-engineered stem cell therapy โ safely delivers interferon-ฮฑ into glioblastoma tumors with no dose-limiting toxicities.
Autologous NK cell therapy combined with immunotherapy tested in 27 patients with treatment-resistant cancers.
Scientists develop innovative immunotherapy that reprograms multiple immune cell types to attack cancer while reducing side effects.